Canada markets closed

CRISPR Therapeutics AG (1CG.SG)

Stuttgart - Stuttgart Delayed Price. Currency in EUR
Add to watchlist
40.800.00 (0.00%)
At close: 08:10AM CEST
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
370,000
370,000
436
913,081
543
Cost of Revenue
130,250
130,250
110,250
101,178
-
Gross Profit
239,750
239,750
-109,814
811,903
-
Operating Expenses
Research Development
387,332
387,332
461,645
340,567
266,946
Selling General and Administrative
76,162
76,162
102,464
99,690
88,208
Total Operating Expenses
462,288
462,288
563,347
438,375
354,978
Operating Income or Loss
-222,538
-222,538
-673,161
373,528
-354,435
Total Other Income/Expenses Net
71,816
71,816
22,661
6,003
6,379
Income Before Tax
-150,722
-150,722
-650,500
379,531
-348,056
Income Tax Expense
2,888
2,888
-325
1,870
809
Income from Continuing Operations
-153,610
-153,610
-650,175
377,661
-348,865
Net Income
-153,610
-153,610
-650,175
377,661
-348,865
Net Income available to common shareholders
-153,610
-153,610
-650,175
377,661
-348,865
Basic EPS
4.97
-1.94
-8.36
4.97
-5.29
Diluted EPS
4.70
-1.94
-8.36
4.70
-5.29
Basic Average Shares
75,949
79,221
77,747
75,949
65,950
Diluted Average Shares
80,393
79,221
77,747
80,393
65,950